Knight Jeff E.'s Form 4 filing
Crinetics Pharmaceuticals, Inc. (CRNX) · filed Jul 17, 2024
- Accession no.
- 0000950170-24-084346
- Filed
- Jul 17, 2024
- Trade date
- Jul 15, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.49M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Knight Jeff E.CIK 0001881007 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | Common Stock | MOption exerciseAcquired | +17,499 | $23.98 | +$419,626.02 | 70,079 | Direct | |
| Jul 15, 2024 | Common Stock | MOption exerciseAcquired | +2,887 | $20.02 | +$57,797.74 | 72,966 | Direct | |
| Jul 15, 2024 | Common Stock | MOption exerciseAcquired | +5,687 | $19.64 | +$111,692.68 | 78,653 | Direct | |
| Jul 15, 2024 | Common Stock | SSaleDisposed | −27,000 | $55.00 | −$1,485,000 | 51,653 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | Common Stock | MOption exerciseDisposed | −17,499 | $0.00 | $0 | 112,501 | Direct | |
| Jul 15, 2024 | Common Stock | MOption exerciseDisposed | −2,887 | $0.00 | $0 | 20,213 | Direct | |
| Jul 15, 2024 | Common Stock | MOption exerciseDisposed | −5,687 | $0.00 | $0 | 85,313 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.